A citation-based method for searching scientific literature

Silvia Carra, Germano Gaudenzi, Alessandra Dicitore, Davide Saronni, Maria Celeste Cantone, Alice Plebani, Anna Ghilardi, Maria Orietta Borghi, Leo J Hofland, Luca Persani, Giovanni Vitale. Int J Mol Sci 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A Phase II study of the safety and efficacy of lenvatinib in patients with advanced thyroid cancer.
Shunji Takahashi, Naomi Kiyota, Tomoko Yamazaki, Naoko Chayahara, Kenji Nakano, Lina Inagaki, Kazuhisa Toda, Tomohiro Enokida, Hironobu Minami, Yoshinori Imamura,[...]. Future Oncol 2019
71
100

Anlotinib in Locally Advanced or Metastatic Medullary Thyroid Carcinoma: A Randomized, Double-Blind Phase IIB Trial.
Dapeng Li, Yihebali Chi, Xiaohong Chen, Minghua Ge, Yuan Zhang, Zhuming Guo, Jun Wang, Jie Chen, Jiewu Zhang, Ying Cheng,[...]. Clin Cancer Res 2021
12
100


A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer.
Martin Schlumberger, Barbara Jarzab, Maria E Cabanillas, Bruce Robinson, Furio Pacini, Douglas W Ball, Judith McCaffrey, Kate Newbold, Roger Allison, Renato G Martins,[...]. Clin Cancer Res 2016
134
100

A phase II trial of imatinib therapy for metastatic medullary thyroid carcinoma.
J W B de Groot, B A Zonnenberg, P Quarles van Ufford-Mannesse, M M de Vries, T P Links, C J M Lips, E E Voest. J Clin Endocrinol Metab 2007
129
100

Advances in the Management of Medullary Thyroid Carcinoma: Focus on Peptide Receptor Radionuclide Therapy.
Erika Grossrubatscher, Giuseppe Fanciulli, Luca Pes, Franz Sesti, Carlotta Dolci, Federica de Cicco, Annamaria Colao, Antongiulio Faggiano, Nike Group. J Clin Med 2020
11
100

Neoadjuvant BRAF- and Immune-Directed Therapy for Anaplastic Thyroid Carcinoma.
Maria E Cabanillas, Renata Ferrarotto, Adam S Garden, Salmaan Ahmed, Naifa L Busaidy, Ramona Dadu, Michelle D Williams, Heath Skinner, G Brandon Gunn, Horiana Grosu,[...]. Thyroid 2018
59
100

Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].
J J Mukherjee, G A Kaltsas, N Islam, P N Plowman, R Foley, J Hikmat, K E Britton, P J Jenkins, S L Chew, J P Monson,[...]. Clin Endocrinol (Oxf) 2001
117
100

The glucose-dependent insulinotropic polypeptide receptor: a novel target for neuroendocrine tumor imaging—first preclinical studies.
Eleni Gourni, Beatrice Waser, Pascal Clerc, Daniel Fourmy, Jean Claude Reubi, Helmut R Maecke. J Nucl Med 2014
24
100

Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors.
Alain Roche, Baragur V Girish, Thierry de Baère, Eric Baudin, Valérie Boige, Dominique Elias, Philippe Lasser, Martin Schlumberger, Michel Ducreux. Eur Radiol 2003
174
100

Updates in the advances of sporadic medullary thyroid carcinoma: from the molecules to the clinic.
Yanhua Bai, Dongfeng Niu, Qian Yao, Dongmei Lin, Kennichi Kakudo. Gland Surg 2020
4
100

Synergistic activity of everolimus and 5-aza-2'-deoxycytidine in medullary thyroid carcinoma cell lines.
Giovanni Vitale, Alessandra Dicitore, Daniele Pepe, Davide Gentilini, Elisa S Grassi, Maria O Borghi, Giulia Gelmini, Maria C Cantone, Germano Gaudenzi, Gabriella Misso,[...]. Mol Oncol 2017
21
100

Preliminary report of the use of everolimus in a patient with progressive medullary thyroid carcinoma.
Maralyn Druce, Teng-Teng Chung, Simona Grozinsky-Glasberg, David J Gross, Ashley B Grossman. Clin Endocrinol (Oxf) 2012
15
100



Role of tissue and circulating microRNAs and DNA as biomarkers in medullary thyroid cancer.
Martina Chiacchiarini, Sofia Trocchianesi, Zein Mersini Besharat, Agnese Po, Elisabetta Ferretti. Pharmacol Ther 2021
4
100

Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
S Filetti, C Durante, D Hartl, S Leboulleux, L D Locati, K Newbold, M G Papotti, A Berruti. Ann Oncol 2019
211
100

ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration.
Stephen R Wedge, Donald J Ogilvie, Michael Dukes, Jane Kendrew, Rosemary Chester, Janet A Jackson, Sarah J Boffey, Paula J Valentine, Jon O Curwen, Helen L Musgrove,[...]. Cancer Res 2002
721
100


Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAFV600E-Mutated Anaplastic Thyroid Carcinoma.
Jennifer R Wang, Mark E Zafereo, Ramona Dadu, Renata Ferrarotto, Naifa L Busaidy, Charles Lu, Salmaan Ahmed, Maria K Gule-Monroe, Michelle D Williams, Erich M Sturgis,[...]. Thyroid 2019
74
100


Sequelae and survivorship in patients treated with (131)I-MIBG therapy.
W C C Sze, A B Grossman, I Goddard, D Amendra, S C C Shieh, P N Plowman, W M Drake, S A Akker, M R Druce. Br J Cancer 2013
19
100

RET Kinase-Regulated MicroRNA-153-3p Improves Therapeutic Efficacy in Medullary Thyroid Carcinoma.
Lauren Jin Suk Joo, Jocelyn Weiss, Anthony J Gill, Roderick Clifton-Bligh, Himanshu Brahmbhatt, Jennifer A MacDiarmid, Matti L Gild, Bruce G Robinson, Jing Ting Zhao, Stan B Sidhu. Thyroid 2019
14
100

NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018.
Robert I Haddad, Christian Nasr, Lindsay Bischoff, Naifa Lamki Busaidy, David Byrd, Glenda Callender, Paxton Dickson, Quan-Yang Duh, Hormoz Ehya, Whitney Goldner,[...]. J Natl Compr Canc Netw 2018
131
100

Comparison of 68Ga PET/CT to Other Imaging Studies in Medullary Thyroid Cancer: Superiority in Detecting Bone Metastases.
Luciana Audi Castroneves, George Coura Filho, Ricardo Miguel Costa de Freitas, Raphael Salles, Raquel Ajub Moyses, Rossana Veronica Mendoza Lopez, Maria Adelaide Albergaria Pereira, Marcos Roberto Tavares, Alexander Augusto de Lima Jorge, Carlos Alberto Buchpiguel,[...]. J Clin Endocrinol Metab 2018
20
100


Cholecystokinin 2 Receptor Agonist 177Lu-PP-F11N for Radionuclide Therapy of Medullary Thyroid Carcinoma: Results of the Lumed Phase 0a Study.
Christof Rottenburger, Guillaume P Nicolas, Lisa McDougall, Felix Kaul, Michal Cachovan, A Hans Vija, Roger Schibli, Susanne Geistlich, Anne Schumann, Tilman Rau,[...]. J Nucl Med 2020
25
100

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Bryan R Haugen, Erik K Alexander, Keith C Bible, Gerard M Doherty, Susan J Mandel, Yuri E Nikiforov, Furio Pacini, Gregory W Randolph, Anna M Sawka, Martin Schlumberger,[...]. Thyroid 2016
100

Posterior reversible encephalopathy syndrome and takotsubo cardiomyopathy associated with lenvatinib therapy for thyroid cancer: a case report and review.
Young Kwang Chae, Lauren Chiec, Scott K Adney, Josh Waitzman, Ricardo Costa, Benedito Carneiro, Maria Matsangou, Mark Agulnik, Peter Kopp, Frank Giles. Oncotarget 2018
6
100

Synergistic cooperation between sunitinib and cisplatin promotes apoptotic cell death in human medullary thyroid cancer.
Alessia Lopergolo, Valentina Nicolini, Enrica Favini, Laura Dal Bo, Monica Tortoreto, Denis Cominetti, Marco Folini, Paola Perego, Vittoria Castiglioni, Eugenio Scanziani,[...]. J Clin Endocrinol Metab 2014
18
100

Anlotinib for the Treatment of Patients with Locally Advanced or Metastatic Medullary Thyroid Cancer.
Yongkun Sun, Feng Du, Ming Gao, Qinghai Ji, Zhendong Li, Yuan Zhang, Zhuming Guo, Jun Wang, Xiangjin Chen, Jinwan Wang,[...]. Thyroid 2018
61
100

Beneficial Effects of the mTOR Inhibitor Everolimus in Patients with Advanced Medullary Thyroid Carcinoma: Subgroup Results of a Phase II Trial.
T C Schneider, D de Wit, T P Links, N P van Erp, J J M van der Hoeven, H Gelderblom, T van Wezel, R van Eijk, H Morreau, H J Guchelaar,[...]. Int J Endocrinol 2015
34
100

Association Between Programmed Death-Ligand 1 Expression and Clinicopathological Characteristics, Structural Recurrence, and Biochemical Recurrence/Persistent Disease in Medullary Thyroid Carcinoma.
Xiao Shi, Peng-Cheng Yu, Bo-Wen Lei, Cui-Wei Li, Yan Zhang, Li-Cheng Tan, Rong-Liang Shi, Jie Wang, Ben Ma, Wei-Bo Xu,[...]. Thyroid 2019
15
100

A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H.
Keith C Bible, Vera J Suman, Julian R Molina, Robert C Smallridge, William J Maples, Michael E Menefee, Joseph Rubin, Nina Karlin, Kostandinos Sideras, John C Morris,[...]. J Clin Endocrinol Metab 2014
71
100

Postoperative biochemical remission of serum calcitonin is the best predictive factor for recurrence-free survival of medullary thyroid cancer: a large-scale retrospective analysis over 30 years.
Kyong Yeun Jung, Seok-Mo Kim, Won Sang Yoo, Bup-Woo Kim, Yong Sang Lee, Kyung Won Kim, Kyu Eun Lee, Jong Ju Jeong, Kee-Hyun Nam, Se Hoon Lee,[...]. Clin Endocrinol (Oxf) 2016
27
100

Selective RET kinase inhibition for patients with RET-altered cancers.
V Subbiah, V Velcheti, B B Tuch, K Ebata, N L Busaidy, M E Cabanillas, L J Wirth, S Stock, S Smith, V Lauriault,[...]. Ann Oncol 2018
186
100

Novel targeted therapies and immunotherapy for advanced thyroid cancers.
George E Naoum, Michael Morkos, Brian Kim, Waleed Arafat. Mol Cancer 2018
96
100

Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations.
V Subbiah, T Shen, S S Terzyan, X Liu, X Hu, K P Patel, M Hu, M Cabanillas, A Behrang, F Meric-Bernstam,[...]. Ann Oncol 2021
52
100

Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times.
Anne Laure Giraudet, Abir Al Ghulzan, Anne Aupérin, Sophie Leboulleux, Ahmed Chehboun, Frédéric Troalen, Clarisse Dromain, Jean Lumbroso, Eric Baudin, Martin Schlumberger. Eur J Endocrinol 2008
144
100


Pancreatic carcinoids (serotonin-producing pancreatic neuroendocrine neoplasms): Report of 5 cases and review of the literature.
Nikolaos Tsoukalas, Eleftherios Chatzellis, Dimitra Rontogianni, Krystallenia I Alexandraki, Georgios Boutzios, Anna Angelousi, Gregory Kaltsas. Medicine (Baltimore) 2017
11
100

Thyroid carcinoma, version 2.2014.
R Michael Tuttle, Robert I Haddad, Douglas W Ball, David Byrd, Paxton Dickson, Quan-Yang Duh, Hormoz Ehya, Megan Haymart, Carl Hoh, Jason P Hunt,[...]. J Natl Compr Canc Netw 2014
109
100

Ectopic adrenocorticotropic hormone-syndrome in medullary carcinoma of the thyroid: a retrospective analysis and review of the literature.
Sandrine Laboureau-Soares Barbosa, Patrice Rodien, Sophie Leboulleux, Patricia Niccoli-Sire, Jean-Louis Kraimps, Philippe Caron, Françoise Archambeaud-Mouveroux, Bernard Conte-Devolx, Vincent Rohmer. Thyroid 2005
59
100

Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and 68Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human Trial.
Caroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, Aurore Rauscher, Mickael Bourgeois, Evelyne Cerato, Vincent Rohmer, Olivier Couturier, Delphine Drui, David M Goldenberg,[...]. J Nucl Med 2016
40
100

Theranostics in neuroendocrine tumors: an overview of current approaches and future challenges.
Julie Refardt, Johannes Hofland, Antwi Kwadwo, Guillaume P Nicolas, Christof Rottenburger, Melpomeni Fani, Damian Wild, Emanuel Christ. Rev Endocr Metab Disord 2021
12
100

Medullary thyroid carcinoma beyond surgery: advances, challenges, and perspectives.
Lucieli Ceolin, Marta Amaro da Silveira Duval, Antônio Felippe Benini, Carla Vaz Ferreira, Ana Luiza Maia. Endocr Relat Cancer 2019
40
100

Rôle of calcitonin in diarrhoea associated with medullary carcinoma of the thyroid.
T M Cox, E A Fagan, C J Hillyard, D J Allison, V S Chadwick. Gut 1979
49
100

Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors.
Tessa Brabander, Wouter A van der Zwan, Jaap J M Teunissen, Boen L R Kam, Richard A Feelders, Wouter W de Herder, Casper H J van Eijck, Gaston J H Franssen, Eric P Krenning, Dik J Kwekkeboom. Clin Cancer Res 2017
250
100

Benefits and Limitations of TKIs in Patients with Medullary Thyroid Cancer: A Systematic Review and Meta-Analysis.
Zoe A Efstathiadou, Charalambos Tsentidis, Alexandra Bargiota, Vasiliki Daraki, Kalliopi Kotsa, Georgia Ntali, Labrini Papanastasiou, Stelios Tigas, Konstantinos Toulis, Kalliopi Pazaitou-Panayiotou,[...]. Eur Thyroid J 2021
5
100

Chemotherapy and tyrosine-kinase inhibitors for medullary thyroid cancer.
Julien Hadoux, Martin Schlumberger. Best Pract Res Clin Endocrinol Metab 2017
22
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.